Skip to main content
SpringerLink
Log in
Book cover

Drugs Affecting Leukotrienes and Other Eicosanoid Pathways pp 55–71Cite as

Pharmacologic Modulation of Leukotriene Biosynthesis by Incorporation of Alternative Unsaturated Fatty Acids (20:5 and 22:6)

  • Chapter

  • 40 Accesses

Part of the book series: NATO ASI Series ((NSSA,volume 95))

Abstract

The 5-lipoxygenase pathway for oxidative metabolism of unsaturated fatty acids was first recognized less than 10 years ago with the definition of 5S-hydroxy-eicosatetraenoic acid (5-HETE) as a product, l and its potential biological relevance to inflammation was defined solely by the modest chemotactic activity of 5-HETE.2 However, major interest in this pathway did not occur until 5 years ago when leukotriene B4 (LTB4), 5S,12R-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid was first described3 and the elusive “slow reacting substance of anaphylaxis (SRS-A),” was chemically defined as three additional leukotriene products of this pathway: LTC4, 5S-hydroxy-6R-S-glutathionyl-7,9-trans-11,14-cis-eicosatetraenoic acido; LTD4, 5S-hydroxy-6R-S-cysteinylglycyl-7,9-trans-11,14-cis-eicosatetraenoic acid5-7; and LTE4, 5S-hydroxy-6R-S-cysteinyl-7,9-trans-11,14-cis-eicosatetraenoic acid.8 That efforts to decrease the generation of the leukotriene compounds could have a significant effect in down-regulating a variety of inflammatory events has been strongly suggested by several types of data developed over the past 5 years, with regard to the breadth of proinflammatory effects manifested by these compounds, indications that a variety are mediated via specific receptors that do not recognize other naturally-occurring compounds, an expanding knowledge of the inflammatory cell types which serve as sources for the leukotrienes, and the demonstration that leukotrienes are recoverable from complex biological fluids in both in vivo models of inflammation and human disease. Although there is potential for antagonizing the biological effects of each leukotriene at the end-organ receptor level, the present discussion will focus mainly on regulation of leukotriene biosynthesis as an anti-inflammatory therapeutic approach. Furthermore, the potential of dietary alteration as an adjunct to developing pharmacotherapeutic inhibitors of the 5-lipoxygenase pathway will be specifically considered.

Recipient of Allergic Diseases Academic Award AI-00399 from the National Institutes of Health

Recipient of a Saltwell Fellowship, Royal College of Physicians, London, U.K.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. P. Borgeat, M. Hamberg, and B. Samuelsson, Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases, J. Biol. Chem. 251:7816 (1976), and correction: 252: 8772 (1977).

    Google Scholar 

  2. E.J. Goetzl, A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration, Immunology. 40: 709 (1980).

    PubMed  CAS  Google Scholar 

  3. P. Borgeat and B. Samuelsson, Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187, Proc. Natl. Acad. Sci. USA. 76: 2148 (1979).

    Article  PubMed  CAS  Google Scholar 

  4. R.C. Murphy, S. Hammarstr’óm, and B. Samuelsson, Leukotriene C: a slow reacting substance from purine mastocytoma cells, Proc. Natl. Acad. Sci. USA. 76: 4275 (1979).

    Article  PubMed  CAS  Google Scholar 

  5. R.A. Lewis, K.F. Austen, J.M. Drazen, D.A. Clark, A. Marfat, and E.J. Corey, Slow reacting substances of anaphylaxis: identification of leukotriene C-1 and D from human and rat sources, Proc. Natl. Acad. Sci. USA. 77: 3710 (1980).

    Article  PubMed  CAS  Google Scholar 

  6. L. Örning, S. Hammarstr’óm, and B. Samuelsson, Leukotriene D: a slow reacting substance from rat basophilic leukemia cells, Proc. Natl. Acad. Sci. USA. 77: 2014 (1980).

    Article  PubMed  Google Scholar 

  7. H.R. Morris, G.W. Taylor, P.J. Piper, and J.R. Tippins, Structure of slow reacting substance of anaphylaxis from guinea pig lung, Nature. 285: 104 (1980).

    Article  PubMed  CAS  Google Scholar 

  8. R.A. Lewis, J.M. Drazen, K.F. Austen, D.A. Clark, and E.J. Corey, Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis geometry for biological activity, Biochem. Biophys. Res. Commun. 96: 271 (1980).

    Article  CAS  Google Scholar 

  9. W.E. Brocklehurst, The release of histamine and formation of a slow reacting substance of anaphylaxis (SRS-A) during anaphylactic shock, J. Physiol. 151: 416 (1960).

    PubMed  CAS  Google Scholar 

  10. J.M. Drazen, R.A. Lewis, S.I. Wasserman, R.P. Orange, and K.F. Austen, Differential effects of a partially purified preparation of slow reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips, J. Clin. Invest. 63: 1 (1979).

    Article  PubMed  CAS  Google Scholar 

  11. J.M. Drazen, K.F. Austen, R.A. Lewis, D.A. Clark, G. Goto, A. Marfat, and E.J. Corey, Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro, Proc. Natl. Acad. Sci. USA. 77: 4354 (1980).

    Article  PubMed  CAS  Google Scholar 

  12. J.M. Drazen C.S. Venugopalan, K.F. Austen, F. Brion, and E.J. Corey, Effects of leukotriene E on pulmonary mechanics in the guinea pig, Am. Rev. Respir. Dis. 125: 290 (1982).

    PubMed  Google Scholar 

  13. A.G. Leitch, E.J. Corey, K.F. Austen, and J.M. Drazen, Indomethacin potentiates the pulmonary response to aerosol leukotriene C4 in the guinea pig, Amer. Rev. Respir. Dis. 128: 639 (1983).

    CAS  Google Scholar 

  14. G. Smedeg-rd, P. Hedqvist, S.-E. Dahlén, B. Revenus, S. Hammarstr’m, and B. Samuelsson, Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey, Nature. 295: 327 (1982).

    Article  Google Scholar 

  15. J.M. Drazen and K.F. Austen, Effects of intravenous administration of slow reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2a on pulmonary mechanics in the guinea pig, J. Clin. Invest. 53: 1679 (1974).

    Article  PubMed  CAS  Google Scholar 

  16. J.M. Drazen, R.A. Lewis, K.F. Austen, and E.J. Corey, Pulmonary pharmacology of the SRS-A leukotrienes, in: “Leukotrienes and Prostacyclin,” F. Berti, G. Folco, and G Velo, eds., Plenum Press, New York (1983).

    Google Scholar 

  17. M.C. Holroyde, R.E.C. Altounyan, M. Cole, M. Dixon, and E.V. Elliot, Bronchoconstriction produced in man by leukotriene C and D, Lancet. 2: 17 (1981).

    Article  PubMed  CAS  Google Scholar 

  18. J.W. Weiss, J.M. Drazen, N. Coles, E.R. McFadden, Jr., P.F. Weller, E.J. Corey, R.A. Lewis, and K.F. Austen, Bronchoconstrictor effects of leukotriene C in humans, Science. 216: 196 (1982).

    Article  PubMed  CAS  Google Scholar 

  19. J.W. Weiss, J.M. Drazen, E.R. McFadden, Jr., P.F. Weller, E.J. Corey, R.A. Lewis, and K.F. Austen, Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy, J. Amer. Med Assoc. 249: 2814 (1983).

    Article  CAS  Google Scholar 

  20. Z. Marom, J.H. Shelhamer, M.K. Bach, D.R. Morton, and M. Kaliner, Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro, Am. Rev. Respir. Dis. 126: 449 (1982).

    PubMed  CAS  Google Scholar 

  21. S.J. Coles, K.H. Neill, L.M. Reid, K.F. Austen, Y. Nii, E.J. Corey, and R.A. Lewis, Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa, Prostaglandins. 25: 155 (1983).

    Article  PubMed  CAS  Google Scholar 

  22. S.-E. Dahlén, J. Bjork, P. Hedqvist, K.-E. Arfors, S. Hammarström, J.-A. Lindgren, and B. S.muelsson, Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response, Proc. Natl. Acad. Sci. USA. 78: 3887 (1981).

    Google Scholar 

  23. N.A. Soter, R.A. Lewis, E.J. Corey, and K.F. Austen, Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin, J. Invest. Derm. 80: 115 (1983).

    Article  PubMed  CAS  Google Scholar 

  24. F. Michelassi, L. Landa, R.D. Hill, E. Lowenstein, W.D. Watkins, A.J. Petkau, and W.M. Zapol, Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction, Science. 217: 841 (1982).

    Article  PubMed  CAS  Google Scholar 

  25. M.A. Pfeffer, J.M. Pfeffer, R.A. Lewis, E. Braunwald, E.J. Corey, and K.F. Austen, Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat, Am. J. Physiol. 244: H628 (1983).

    PubMed  CAS  Google Scholar 

  26. J. Bittl, M.A. Pfeffer, R.A. Lewis, J.M. Pfeffer, J.S. Ingwall,and K.F. Austen, Mechanism of the negative ionotropic action of leukotrienes C4 and D4 on the isolated rat heart, J. Amer. College Cardiol. 3: 503 (1984).

    Google Scholar 

  27. K.F. Badr, C. Baylis, J.M. Pfeffer, M.A. Pfeffer, R.J. Soberman, R.A. Lewis, K.F. Austen, E.J. Corey, and B.M. Brenner, Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat, Circ. Res. 54: 492 (1984).

    CAS  Google Scholar 

  28. P. Sirois, S. Roy, and P. Borgeat, The lung parenchymal strip as a sensitive assay for leukotriene 84, Prostaglandins Med. 6: 153 (1981).

    Article  PubMed  CAS  Google Scholar 

  29. E.J. Goetzl and W.C. Pickett, The human polymorphonuclear leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs), J. Immunol. 125: 1789 (1980).

    PubMed  CAS  Google Scholar 

  30. R.A. Lewis, J.M. Drazen, E.J. Corey, and K.F. Austen, Structural and functional characteristics of the leukotriene components of slow reacting substance of anaphylaxis (SRS-A), in: “SRS-A and the Leukotrienes,” P.J. Piper, ed., John Wiley and Sons, London (1981).

    Google Scholar 

  31. R.L. Hoover, M.L. Karnovsky, K.F. Austen, E.J. Corey, and R.A. Lewis, Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion, Proc. Natl. Acad. Sci. USA. 81: 2191 (1984).

    Article  PubMed  CAS  Google Scholar 

  32. D. Atluru and J.S. Goodwin, Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes; LTB4 induces an OKT8(+), radiosensitive suppressor cell from resting human OKT8(-) T cells, J. Clin. Invest. (in press).

    Google Scholar 

  33. D.G. Payan and E.J. Goetzl, Specific suppression of human T lymphocyte function by leukotriene 84, J. Immunol. 131: 551 (1983).

    PubMed  CAS  Google Scholar 

  34. M.P. Rola-Plezczynski, P. Borgeat, and P. Sirois, Leukotriene B4 induces human suppressor lymphocytes, Biochem. Biophys. Res. Commun. 198: 1531 (1982).

    Article  Google Scholar 

  35. R.A. Lewis, J.M. brazen, K.F. Austen, M. Toda, F. Brion, A. Marfat, and E.J. Corey, Contractile activities of structural analogs of leukotrienes C and D: role of the polar substituents, Proc. Natl. Acad. Sci. USA. 78: 4579 (1981).

    Article  PubMed  CAS  Google Scholar 

  36. S. Krilis, R.A. Lewis, E.J. Corey, and K.F. Austen, Specific binding of leukotriene C4 on a smooth muscle cell line, J. Clin. Invest. 72: 1516 (1983).

    Article  PubMed  CAS  Google Scholar 

  37. S. Krilis, R.A. Lewis, E.J. Corey, and K.F. Austen, Specific binding of leukotriene C4 to ileal segments and subcellular fractions of ileal smooth muscle, Proc. Natl. Acad. Sci. USA. 81: 4529 (1984).

    Article  PubMed  CAS  Google Scholar 

  38. S.S. Pong, R.N. DeHaven, F.A. Kuehl, Jr., R.W. Egan, Leukotriene C4 binding to rat lung membranes, J. Biol. Chem. 258: 9616 (1983).

    PubMed  CAS  Google Scholar 

  39. G.K. Hogaboom, S. Mong, H.-L. Wu, and S. Crooke, Peptidoleukotrienes: distinct receptors for leukotrienes C4 and D4 in the guinea pig lung, Biochem. Biophys. Res. Commun. 116: 1136 (1983).

    Article  CAS  Google Scholar 

  40. R.F. Bruns, W.J. Thomsen, and T.A. Pugsley, Binding of leukotrienes C4 and D4 to membranes from guinea pig lung: regulation by ions and guanine nucleotides, Life Sci. 33: 645 (1983).

    Article  PubMed  CAS  Google Scholar 

  41. S.S. Pong and R.N. DeHaven, Characterization of a leukotriene D4 receptor in guinea pig lung, Proc. Natl. Acad. Sci. USA. 80: 7415 (1983).

    Article  PubMed  CAS  Google Scholar 

  42. S. Krilis, R.A. Lewis, and K.F. Austen, Classes of receptors for the sulfidopeptide leukotrienes, in: “Icosanoids and Ion Transport,” P. Braquet and B. Samuelsson, eds., Raven Press, New York (in press)

    Google Scholar 

  43. B.J. Ballermann, R.A. Lewis, E.J. Corey, K.F. Austen, and B.M. Brenner, Identification of leukotriene C4 (LTC4) receptors in isolated rat renal glomeruli, Clin. Res. 32: 440A (1984).

    Google Scholar 

  44. E.J. Goetzl and W.C. Pickett, Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B, J. Exp. Med. 153: 482 (1981).

    Article  PubMed  CAS  Google Scholar 

  45. R.A. Lewis, E.J. Goetzl, J.M. Drazen, N.A. Soter, K.F. Austen, and E.J. Corey, Functional characterization of synthetic leukotriene B and its stereochemical isomers, J. Exp. Med. 154: 1243 (1981).

    Article  PubMed  CAS  Google Scholar 

  46. A.W. Ford-Hutchinson, M.A. Bray, F.M. Cunningham, E.M. Davidson, and M.J.H. Smith, Isomers of LTB4 posess different biological potencies, Prostaglandins 21: 143 (1981).

    Article  PubMed  CAS  Google Scholar 

  47. D.W. Goldman and E.J. Goetzl, Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes, J. Immunol. 129: 1600 (1982).

    PubMed  CAS  Google Scholar 

  48. D.W. Goldman and E.J. Goetzl, Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4, J. Allergy Clin. Immunol. (in press).

    Google Scholar 

  49. P.F. Weller, C.W. Lee, D.W. Foster, E.J. Corey, K.F. Austen, and R.A. Lewis, Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4, Proc. Natl. Acad. Sci. USA. 80: 7626 (1983).

    Article  PubMed  CAS  Google Scholar 

  50. C.W. Lee, R.A. Lewis, A.I. Tauber, M. Mehrotra, E.J. Corey, and K.F. Austen, The myeloperoxidase-dependent metabolism of leukotrienes C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides, J. Biol. Chem. 258: 15004 (1983).

    PubMed  CAS  Google Scholar 

  51. A.O. Fels, N.A. Pawlowski, E.B. Cramer, T.K.C. King, Z.A. Cohn, and W.A. Scott, Human alveolar macrophages produce leukotriene B4, Proc. Natl. Acad. Sci. USA. 79: 7866 (1982).

    Article  PubMed  CAS  Google Scholar 

  52. T.R. Martin, L.C. Altman, R.K. Albert, and W.R. Henderson, Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung, Amer. Rev. Respir. Dis. 125: 106 (1984).

    Google Scholar 

  53. P. Godard, M. Damon, F.B. Michel, E.J. Corey, K.F. Austen, and R.A. Lewis, Leukotriene B4 production from human alveolar macrophages, Clin. Res. 31: 548A (1983).

    Google Scholar 

  54. J.D. Williams, J.K Czop, and K.F. Austen, Release of leukotrienes by human monocytes on stimultion of their phagocytic receptor for particulate activators, J. Immunol. 132: 3034 (1984).

    PubMed  CAS  Google Scholar 

  55. D.W. MacGlashan, R. Schleimer, S.P. Peters, E.S. Schulman, G.K. Adams, H.H. Newball, and L.M. Lichtenstein, Generation of leukotrienes by purified human lung mast cells, J. Clin. Invest. 70: 747 (1982).

    Article  PubMed  CAS  Google Scholar 

  56. S.P. Peters, D.W. MacGlashan, E.S. Schulman, R.P. Schleimer, E.C. Hayes, J. Rokach, N.F. Adkinson and L.M. Lichtenstein, Arachidonic acid metabolism in purified human lung mast cells, J. Immunol. 132: 1972 (1984).

    PubMed  CAS  Google Scholar 

  57. T. Shimizu, O. RRdmark, and B. Samuelsson, Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid, Proc. Natl. Acad. Sci. USA. 81: 689 (1984).

    Article  PubMed  CAS  Google Scholar 

  58. Rddmark, C. Malmsten, B. Sanuelssson, G. Goto, A. Marfat, and E.J. Corey, Leukotriene A: isolation from human polymorphonuclear leukocytes, J. Biol. Chem. 255: 11828 (1980).

    Google Scholar 

  59. A.L. Maycock, M.S. Anderson, D.M. DeSousa, and F.A. Kuehl, Jr., Leukotriene A4: preparation and enzymatic conversion in a cell-free system to leukotriene B4, J. Biol. Chem. 257: 13911 (1982).

    PubMed  CAS  Google Scholar 

  60. M.K. Bach, J.R. Brashler, and D.R. Morton, Jr., Solubilization and characterization of the leukotriene C4 synthetase of rat basophil leukemia cells: a novel, particulate glutathione-S-transferase, Arch. Biochem. Biophys. 230: 455 (1984).

    Article  CAS  Google Scholar 

  61. R.A. Lewis and K.F. Austen, The biologically active leukotrienes: biosynthesis, metabolism, receptors, functions, and pharmacology, J. Clin. Invest. 73: 889 (1984).

    Article  PubMed  CAS  Google Scholar 

  62. E.J. Corey, H. Park, A. Barton, and Y. Nii, Synthesis of three potential inhibitors of the biosynthesis of leukotrienes A-E, Tetrahedron Lett. 21: 4243 (1980).

    Article  CAS  Google Scholar 

  63. E. Razin, L.C. Romeo, S. Krilis, F.-T. Liu, R.A.Lewis, E.J. Corey, and K.F. Austen, An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells, J. Immunol. 133: 938 (1984).

    PubMed  CAS  Google Scholar 

  64. M.K. Bach, J.R. Brashler, H.W. Smith, F.A. Fitzpatrick, F.F. Sun, and J.C. Maguire, 6,9-deepoxy-6,9-(phenylimino)-a638_ prostaglandin Il (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies, Prostaglandins 23: 759 (1982).

    CAS  Google Scholar 

  65. B.M. Weichman, M.A. Wasserman, D.A. Holden, R.R. Osborn, D.F. Woodward, T.W. Ku, and J.G. Gleason, Antagonism of the pulmonary effects of the peptidoleukotrienes by a leukotriene D4 analog, J. Pharmacol. Exp. Ther. 227: 700 (1983).

    PubMed  CAS  Google Scholar 

  66. R.C. Murphy, W.C. Pickett, B.R. Culp, and W.E.M. Lands, Tetraene and pentaene leukotrienes: selective production from murine mastocytoma cells after dietary manipulation, Prostaglandins. 22: 613 (1981).

    Article  PubMed  CAS  Google Scholar 

  67. J.D. Prickett, D.R. Robinson, and A.D. Steinberg, Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice, J. Clin. Invest. 68: 556 (1981).

    Article  PubMed  CAS  Google Scholar 

  68. J.D. Prickett, D.W. Trentham, and D.R. Robinson, Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen, J. Immunol. 132: 725 (1984).

    PubMed  CAS  Google Scholar 

  69. E.J. Corey, C. Shih, and J.R. Cashman, Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis, Proc. Natl. Acad. Sci. USA 80: 3581 (1983).

    Article  PubMed  CAS  Google Scholar 

  70. R.P.Orange, M.D. Valentine, and K.F. Austen, Antigen-induced release of slow reacting substance of anaphylaxis (SRS-Arat) in rats prepared with homologous antibody, J. Exp. Med. 127: 767 (1968).

    Article  Google Scholar 

  71. A.G. Leitch, T.H. Lee, E.W. Ringel, J.D Prickett, D.R. Robinson, S.G. Pyne, E.J. Corey, J.M. Drazen, K.F. Austen, and R.A. Lewis, Immunologically-induced generation of tetraene and pentaene leukotrienes in the peritoneal cavities of menhaden-fed rats, J. Immunol. 132: 2559 (1984).

    PubMed  CAS  Google Scholar 

  72. T.H. Lee, J.-M. Mencia-Huerta, C. Shih, E.J. Corey, R.A. Lewis, and K.F. Austen, Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product, J. Biol. Chem. 259: 2383 (1984).

    PubMed  CAS  Google Scholar 

  73. S. Hammarström, Conversion of 14C-labeled eicosapentaenoic acid (N-3) to leukotriene C5, Biochim. Biophys. Acta. 663: 575 (1981).

    Google Scholar 

  74. S.-E. Dahldn, P. Hedqvist, and S. Hammarström, Contractile activities of several cysteine-containing leukotrienes in the guinea pig lung strip, Eur. J. Pharmacol. 86: 207 (1982).

    Article  Google Scholar 

  75. T.H. Lee, R.A. Lewis, D.R. Robinson, J.M. Drazen, and K.F. Austen, The effects of a diet enriched in menhaden fish oil on the pulmonary response to antigen challenge, J. Allergy Clin. Immunol. 73: 150 (1984).

    Article  Google Scholar 

  76. E.A. Ham, D.D. Soderman, M.E. Zanetti, H.W. Dougherty, E. McCauley, and F.A. Kuehl, Jr., Inhibition by prostaglandins of leukotriene B4 release from activated neutrophil, Proc. Natl. Acad. Sci. USA. 80: 4349 (1983).

    Article  CAS  Google Scholar 

  77. L. Levine, R. Morgan, R.A. Lewis, K.F. Austen, D.A. Clark, A. Marfat, and E.J. Corey, Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis (SRS-A), Proc. Natl. Acad. Sci. USA. 78: 7692 (1981).

    Article  PubMed  CAS  Google Scholar 

  78. E.C. Hayes, D.L. Lombardo, Y. Girard, A.L. Maycock, J. Rokach A.S. Rosenthal, R.M. Young, R.W. Egan, and H.J. Zweerink, Measuring leukotrienes of slow reacting substance of anaphylaxis: development of specific radioimmunoassay, J. Immunol. 131: 429 (1983).

    PubMed  CAS  Google Scholar 

  79. K. Ochi, T. Yoshimoto, S. Yamamoto, K. Taniguchi, and T. Miyamoto, Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes, J. Biol. Chem. 258: 5754 (1983).

    PubMed  CAS  Google Scholar 

  80. R.J. Soberman, R.A. Lewis, E.J. Corey, and K.F. Austen, The characterization of two lipoxygenases from the human PMN, Fed. Proc. 43: 1879 (1984).

    Google Scholar 

  81. T.H. Lee, J.-M. Mencia-Huerta, C. Shih, E.J. Corey, R.A. Lewis, and K.F. Austen, Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophoreactivated human neutrophils, J. Clin. Invest. (in press).

    Google Scholar 

  82. S. Fischer, C.V. Schacky, W. Siess, T. Strasser, and P.C. Weber, Uptake, release and metabolism of docosahexaenoic acid in human platelets and neutrophils, Biochem. Biophys. Res. Commun. 120: 907 (1984).

    Article  CAS  Google Scholar 

  83. H.O. Bang, and J. Dyerberg, Lipid metabolism and ischemic heart disease in Greenland Eskimoes, Adv. Lipid Res. 3: 1 (1980).

    CAS  Google Scholar 

  84. H. Herxheimer and O. Shaefer, Asthma in Canadian Eskimoes, N. Engl. J. Med. (correspondence) 291: 1419 (1974).

    CAS  Google Scholar 

  85. J. Dyerberg, H.O. Bang, G. Stoffersen, S. Moncada, and J.R. Vane, Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis, Lancet. 1: 117 (1978).

    Article  Google Scholar 

  86. P. Needleman, A. Raz, N.S. Minkes, A. Ferendelli, and H. Sprecher, Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties, Proc. Natl. Acad. Sci. USA. 76: 944 (1979).

    Article  PubMed  CAS  Google Scholar 

  87. G.H.R. Rai, E. Radha, and J.G. White, Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function, Biochem. Biophys. Res. Commun. 117: 5498 (1983).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA

    Robert A. Lewis, Tak H. Lee & K. Frank Austen

  2. Department of Rheumatology and Immunology, Brigham and Women’s Hospital, Boston, MA, 02115, USA

    Robert A. Lewis, Tak H. Lee & K. Frank Austen

Authors
  1. Robert A. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tak H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Frank Austen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Karolinska Institute, Stockholm, Sweden

    B. Samuelsson

  2. University of Milan, Milan, Italy

    F. Berti  & G. C. Folco  & 

  3. University of Verona, Verona, Italy

    G. P. Velo

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Lewis, R.A., Lee, T.H., Austen, K.F. (1985). Pharmacologic Modulation of Leukotriene Biosynthesis by Incorporation of Alternative Unsaturated Fatty Acids (20:5 and 22:6). In: Samuelsson, B., Berti, F., Folco, G.C., Velo, G.P. (eds) Drugs Affecting Leukotrienes and Other Eicosanoid Pathways. NATO ASI Series, vol 95. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7841-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-7841-9_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-7843-3

  • Online ISBN: 978-1-4684-7841-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation